# Febuxostat

## Feburic 80mg

| TAH Drug Code      | [OFEB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OFEB)                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Used to treat hyperuricemia in patients with chronic gout. Not recommended for asymptomatic hyperuricemia. Used in adult patients at moderate to high risk of tumor lysis syndrome (TLS) due to chemotherapy for hematologic malignancies, to prevent and treat hyperuricemia.                                                                                                                                                    |
| Dosing             | Gout: Initial dose: 40mg QD. If the serum uric acid concentration is not lower than 6mg/dL after taking the medicine for 2 weeks, change to 80mg QD. Tumor lysis syndrome: Two days before the start of cytotoxic drug treatment, 80 mg QD for 7 days. According to the clinical response during chemotherapy, it can be extended to 9 days.                                                                                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Hypersensitivity. Concomitant use of azathioprine or mercaptopurine.                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Common: Rash (0.5-1.6%), Diarrhea (>1%), Nausea (1.1-1.3%), Arthralgia (0.7-1.1%) Serious: Myocardial infarction, Drug reaction with eosinophilia and systemic symptoms, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Abnormal liver function (4.6-6.6%), ALT/SGPT level raised (3%), Aspartate aminotransferase serum level above reference range (2%), Gout, acute, Myositis, Rhabdomyolysis, Cerebrovascular accident |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                            |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/febuxostat-drug-information)                                                                                                                                                                                                                                                                                                                                                         |

